Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

173 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Enhanced T cell-independent antibody responses in c-Jun N-terminal kinase 2 (JNK2)-deficient B cells following stimulation with CpG-1826 and anti-IgM.
Cao Y, Takada E, Hata K, Sudo K, Furuhata M, Mizuguchi J. Cao Y, et al. Immunol Lett. 2010 Aug 16;132(1-2):38-44. doi: 10.1016/j.imlet.2010.05.006. Immunol Lett. 2010. PMID: 20665951
Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo.
Toyota H, Yanase N, Yoshimoto T, Harada M, Kato Y, Mizuguchi J. Toyota H, et al. Among authors: mizuguchi j. Oncol Rep. 2015 Jan;33(1):292-6. doi: 10.3892/or.2014.3603. Epub 2014 Nov 12. Oncol Rep. 2015. PMID: 25394516
C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines.
Mikami T, Koyama T, Koyama T, Imakiire A, Yamamoto K, Furuhata M, Toyota H, Mizuguchi J. Mikami T, et al. Anticancer Res. 2006 Mar-Apr;26(2A):1153-60. Anticancer Res. 2006. PMID: 16619517
IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner.
Chiba Y, Mizoguchi I, Mitobe K, Higuchi K, Nagai H, Nishigori C, Mizuguchi J, Yoshimoto T. Chiba Y, et al. Among authors: mizuguchi j. PLoS One. 2013 Oct 14;8(10):e76159. doi: 10.1371/journal.pone.0076159. eCollection 2013. PLoS One. 2013. PMID: 24155891 Free PMC article.
173 results
Jump to page
Feedback